Obese Hypertension Study (0954-315)

Organon

Status and phase: Completed; Phase 3

Conditions: Hypertension

Treatments: Drug: Comparator: Placebo; Drug: Comparator: losartan +/- HCTZ

Study type: Interventional

Funder types: Industry

Identifiers

NCT00289887

0954-315

2006_002

MK0954-315

Details and patient eligibility

About

This is a 16-week study to evaluate high systolic and diastolic blood pressure following treatment in obese, hypertensive, adult patients.

Enrollment: 261 patients

Sex: All

Ages: 21 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Obese male and female patients, ages 21-75 years, with high blood pressure

Exclusion criteria

• Patients cannot have any other severe cardiac conditions

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

261 participants in 2 patient groups, including a placebo group

1

Experimental group

Description:

Losartan

Treatment:

Drug: Comparator: losartan +/- HCTZ

2

Placebo Comparator group

Description:

Placebo

Treatment:

Drug: Comparator: Placebo